(-0.22%) 5 011.12 points
(0.06%) 37 775 points
(-0.52%) 15 601 points
(-0.31%) $82.47
(-0.46%) $1.749
(-0.31%) $2 390.60
(-0.55%) $28.23
(-0.75%) $947.30
(0.08%) $0.940
(0.26%) $11.07
(0.07%) $0.805
(0.10%) $94.15
Live Chart Being Loaded With Signals
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China...
Stats | |
---|---|
Today's Volume | 2.53M |
Average Volume | 2.37M |
Market Cap | 55.84B |
EPS | HKD0.320 ( 2023-10-27 ) |
Last Dividend | HKD0.664 ( 2023-07-18 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 9.80 |
ATR14 | HKD0.00600 (0.06%) |
Volume Correlation
Shanghai Pharmaceuticals Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shanghai Pharmaceuticals Correlation - Currency/Commodity
Shanghai Pharmaceuticals Financials
Annual | 2023 |
Revenue: | HKD260.30B |
Gross Profit: | HKD31.33B (12.04 %) |
EPS: | HKD1.020 |
Q4 | 2023 |
Revenue: | HKD62.79B |
Gross Profit: | HKD7.37B (11.73 %) |
EPS: | HKD0 |
Q3 | 2023 |
Revenue: | HKD64.92B |
Gross Profit: | HKD6.90B (10.63 %) |
EPS: | HKD0.320 |
Q2 | 2023 |
Revenue: | HKD66.37B |
Gross Profit: | HKD8.42B (12.69 %) |
EPS: | HKD0.300 |
Financial Reports:
No articles found.
Shanghai Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.984 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.664 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.196 | 2012-06-14 |
Last Dividend | HKD0.664 | 2023-07-18 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | HKD5.57 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.92 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.21 | |
Div. Directional Score | 7.63 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2327.HK | Ex Dividend Junior | 2023-08-03 | Sporadic | 0 | 0.00% | |
1299.HK | Ex Dividend Knight | 2023-09-08 | Semi-Annually | 0 | 0.00% | |
0366.HK | Ex Dividend Junior | 2023-09-25 | Semi-Annually | 0 | 0.00% | |
6099.HK | Ex Dividend Junior | 2023-07-14 | Annually | 0 | 0.00% | |
1858.HK | Ex Dividend Knight | 2023-06-30 | Annually | 0 | 0.00% | |
0882.HK | Ex Dividend Junior | 2023-09-25 | Semi-Annually | 0 | 0.00% | |
0031.HK | Ex Dividend Junior | 2023-06-26 | Annually | 0 | 0.00% | |
2669.HK | Ex Dividend Knight | 2023-06-23 | Semi-Annually | 0 | 0.00% | |
1432.HK | Ex Dividend Junior | 2023-06-19 | Insufficient data to determine frequency | 0 | 0.00% | |
0520.HK | Ex Dividend Junior | 2023-10-05 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0145 | 1.500 | 9.71 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0178 | 1.200 | 9.41 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0552 | 1.500 | -0.498 | -0.746 | [0.1 - 1] |
payoutRatioTTM | 1.057 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.327 | 0.800 | 8.36 | 6.69 | [1 - 3] |
quickRatioTTM | 1.017 | 0.800 | 8.73 | 6.98 | [0.8 - 2.5] |
cashRatioTTM | 0.249 | 1.500 | 9.73 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.216 | -1.500 | 6.39 | -9.59 | [0 - 0.6] |
interestCoverageTTM | 4.07 | 1.000 | 9.60 | 9.60 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.54 | 2.00 | 9.15 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.737 | 2.00 | 9.13 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.669 | -1.500 | 7.32 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.120 | 1.000 | -1.327 | -1.327 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0295 | 1.000 | -1.411 | -1.411 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.204 | 1.000 | 9.98 | 9.98 | [0.2 - 2] |
assetTurnoverTTM | 1.228 | 0.800 | 5.15 | 4.12 | [0.5 - 2] |
Total Score | 11.05 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 9.71 | 1.000 | 9.12 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0552 | 2.50 | -0.320 | -0.746 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.737 | 2.00 | 9.42 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 6.69 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.54 | 2.00 | 9.15 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.057 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.0429 | 1.500 | -3.05 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0360 | 1.000 | -1.600 | 0 | [0.1 - 0.5] |
Total Score | 4.21 |
Shanghai Pharmaceuticals
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators